What is the better treatment for single digit dupuytren's contracture: surgical release or collagenase clostridium histolyticum (Xiapex) injection?

Hand Surg. 2014;19(3):389-92. doi: 10.1142/S0218810414500324. Epub 2014 Aug 25.

Abstract

The purpose of this study was to compare the initial and final outcome range of motion in the MCP-J and PIP-J of single digit Dupuytren's Contracture treated with either open surgical excision or manipulation after collagenase clostridium histolyticum (CCH; Xiapex) injection.

Material: Ten patients in either group. The range of motion measurements were statistically compared using the student t-test with a p-value of 0.05. There was no statistical difference in the pre-treatment status of the total active range of movement (TAM) between the two groups.

Results: Open surgical release achieved a statistically better initial outcome in combined total passive range of movement than the xiapex group (p = 0.0047), but at the final outcome the better TAM measurement at the MCP-J after surgery was not statistically significant. However, the total active range of movement was statistically better at the PIP-J level in the xiapex group (p = 0.01) and the MCP-J and PIP-J combined total active range of movement was statistically better in the xiapex group (p = 0.0258).

Conclusion: Surgery achieved better initial outcome at both MCP-J and PIP-J levels, and at discharge, only extension in the MCP-J level was statistically better after open excision. However the final outcome was statistically better at the PIP-J level in extension (p = 0.006) and total active movement (TAM) (p = 0.008) after treatment with collagenase clostridium histolyticum. Further studies are required to assess the long-term differences between the two groups and to investigate the outcomes for patients with multi-digit involvement.

Keywords: Comparison; Dupuytren's Contracture; Outcome; Recovery; Surgical Release; Xiapex Injection.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Collagenases / therapeutic use*
  • Decompression, Surgical*
  • Dupuytren Contracture / therapy*
  • Fasciotomy*
  • Follow-Up Studies
  • Humans
  • Injections
  • Prospective Studies
  • Range of Motion, Articular
  • Recovery of Function
  • Time Factors
  • Treatment Outcome

Substances

  • Collagenases
  • xiapex